Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Effects of Abcg2 C421a and Abcg2 G34a Genetic Polymorphisms on Clinical Outcome and Response to Imatinib Mesylate, in Iranian Chronic Myeloid Leukemia Patients
Mohsen Nikbakht
Mohsen Nikbakht

Associate Professor of Medical Biotechnology

Shariati Hospital

Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center

Tehran University of Medical Sciences

Related Documents
All Documents
18. The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (Aml)?, International Journal of Hematology-Oncology and Stem Cell Research (2022)
25. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)
27. Effects of Mobilized Peripheral Blood Stem Cells on Treatment of Primary Lower Extremity Lymphedema, Journal of Vascular Surgery: Venous and Lymphatic Disorders (2020)
33. Sorafenib and Mesenchymal Stem Cell Therapy: A Promising Approach for Treatment of Hcc, Evidence-based Complementary and Alternative Medicine (2020)
49. Anti-Apoptotic Effects of Osteopontin Via the Up-Regulation of Akt/Mtor/Β-Catenin Loop in Acute Myeloid Leukemia Cells, International Journal of Hematology-Oncology and Stem Cell Research (2017)